Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|December 30, 2020
Flow Cytometry Analysis of Circulating Extracellular Vesicle Subtypes from Fresh Peripheral Blood SamplesMarco Marchisio, Pasquale Simeone, Giuseppina Bologna, et al.
ACS Pharmacology & Translational Science|October 16, 2025
Genetic Deletion of the Purinergic Receptor <i>P2rx7</i> Worsens the Phenotype of α‑Sarcoglycan Muscular DystrophyCecilia Astigiano, Elisa Principi, Sara Pintus, et al.
Journal of Clinical Immunology|November 17, 2025
Neurological Phenotypes of SOCS1 Haploinsufficiency: Insights from Functional and Histological InvestigationsSerena Palmeri, Ignazia Prigione, Francesca Schena, et al.
Brain : a Journal of Neurology|October 28, 2025
Muscle transcriptomics of alpha-sarcoglycanopathy highlights inflammatory pathways driving diseaseAdriana Amaro, Francesco Reggiani, Chiara Panicucci, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2022
Spontaneous NLRP3 inflammasome-driven IL-1-β secretion is induced in severe COVID-19 patients and responds to anakinra treatmentArinna Bertoni, Federica Penco, Hilaria Mollica, et al.
Cancer Immunology Research|April 4, 2019
Accumulation of Circulating CCR7<sup>+</sup> Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic PathwayCostanza Maria Cristiani, Alice Turdo, Valeria Ventura, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 3, 2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapyChiara Brignole, Veronica Bensa, Nuno A Fonseca, et al.
The Journal of Rheumatology|September 17, 2017
Cryopyrin-associated Periodic Syndromes in Italian Patients: Evaluation of the Rate of Somatic NLRP3 Mosaicism and Phenotypic CharacterizationDenise Lasigliè, Anna Mensa-Vilaro, Denise Ferrera, et al.
Journal of Clinical Immunology|June 15, 2025
NET Proteomic Profiling Reveals New Pathways Potentially Implicated in Dendritic Cell-Mediated Inflammation in DADA2 PatientsSara Signa, Martina Bartolucci, Martina Bonacini, et al.
Frontiers in Immunology|November 22, 2021
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK CellsFabio Guolo, Paola Minetto, Silvia Pesce, et al.
Pageof 6